Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9629242rdf:typepubmed:Citationlld:pubmed
pubmed-article:9629242lifeskim:mentionsumls-concept:C0021757lld:lifeskim
pubmed-article:9629242lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:9629242lifeskim:mentionsumls-concept:C0080096lld:lifeskim
pubmed-article:9629242pubmed:dateCreated1998-7-9lld:pubmed
pubmed-article:9629242pubmed:abstractTextWe have previously demonstrated that interleukin 3 (IL-3) has a neurotrophic effect on central cholinergic neurons and have demonstrated the presence of IL-3 receptor (IL-3R)beta subunits in septal cholinergic neurons by reverse-transcribed polymerase chain reaction (RT-PCR) and immunohistochemistry. In order to confirm that the expressed IL-3R is functional, we conducted experiments to show an alpha subunit of IL-3R. The alpha subunit was clearly demonstrated by RT-PCR in the central cholinergic neuronal hybrid cell line SN6, but not in its mother cell line N18TG2, and the expression was slightly upregulated after IL-3 treatment. Choline acetyltransferase and vesicular acetylcholine transporter mRNAs were significantly increased in SN6 after treatment with IL-3. Immunohistochemically, IL-3R alpha-positive cells were mainly present in the medial septal and basal forebrain region, and the stained cells were similar to choline acetyltransferase-positive cells in shape and distribution. The IL-3R alpha-positive cells slightly increased two days after fimbria-fornix transection and decreased seven days after. These findings suggest that functional IL-3 receptors are expressed in the central cholinergic neurons and contribute to some physiological roles such as the differentiation and maintenance of these neurons.lld:pubmed
pubmed-article:9629242pubmed:languageenglld:pubmed
pubmed-article:9629242pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9629242pubmed:citationSubsetIMlld:pubmed
pubmed-article:9629242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9629242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9629242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9629242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9629242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9629242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9629242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9629242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9629242pubmed:statusMEDLINElld:pubmed
pubmed-article:9629242pubmed:monthMaylld:pubmed
pubmed-article:9629242pubmed:issn0077-8923lld:pubmed
pubmed-article:9629242pubmed:authorpubmed-author:TabiraTTlld:pubmed
pubmed-article:9629242pubmed:authorpubmed-author:KonishiYYlld:pubmed
pubmed-article:9629242pubmed:authorpubmed-author:ShirabeTTlld:pubmed
pubmed-article:9629242pubmed:authorpubmed-author:ChuiD HDHlld:pubmed
pubmed-article:9629242pubmed:authorpubmed-author:LinL LLLlld:pubmed
pubmed-article:9629242pubmed:issnTypePrintlld:pubmed
pubmed-article:9629242pubmed:day1lld:pubmed
pubmed-article:9629242pubmed:volume840lld:pubmed
pubmed-article:9629242pubmed:ownerNLMlld:pubmed
pubmed-article:9629242pubmed:authorsCompleteYlld:pubmed
pubmed-article:9629242pubmed:pagination107-16lld:pubmed
pubmed-article:9629242pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:meshHeadingpubmed-meshheading:9629242-...lld:pubmed
pubmed-article:9629242pubmed:year1998lld:pubmed
pubmed-article:9629242pubmed:articleTitleInterleukin-3 and interleukin-3 receptors in the brain.lld:pubmed
pubmed-article:9629242pubmed:affiliationDivision of Demyelinating Disease and Aging, National Institute of Neuroscience, Tokyo, Japan. tabira@ncnaxp.ncnp.go.jplld:pubmed
pubmed-article:9629242pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9629242pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3562entrezgene:pubmedpubmed-article:9629242lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9629242lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9629242lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9629242lld:pubmed